FRNM (FRNM)
16.31
-0.59 (3.49%)
Latest Headlines
Form EFFECT Freenome, Inc.
August 28, 2026 6:08 AM - SEC Filing
Form 424B3 Freenome, Inc.
August 27, 2026 4:30 PM - SEC Filing
Guggenheim Starts Freenome Inc. (FRNM) at Buy
August 20, 2026 6:19 AM - StreetInsider
Form S-1 Freenome, Inc.
August 18, 2026 4:52 PM - SEC Filing
TD Cowen Starts Freenome Inc. (FRNM) at Buy
August 18, 2026 5:33 AM - StreetInsider
BTIG Starts Freenome Inc. (FRNM) at Buy
August 17, 2026 5:31 AM - StreetInsider
Jefferies Starts Freenome Inc. (FRNM) at Buy
August 17, 2026 2:30 AM - StreetInsider
Form SCHEDULE 13G/A Freenome, Inc. Filed by: ADAR1 Capital Management, LLC
August 14, 2026 5:00 PM - SEC Filing
Form SCHEDULE 13G Freenome, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
August 14, 2026 12:36 PM - SEC Filing
Leerink Starts Freenome Inc. (FRNM) at Outperform
August 14, 2026 6:12 AM - StreetInsider
Form 8-K/A Freenome, Inc. For: Jul 20
August 13, 2026 5:29 PM - SEC Filing
Form SCHEDULE 13G/A Freenome, Inc. Filed by: IPConcept (Luxemburg) S.A.
August 12, 2026 5:34 PM - SEC Filing
Form SCHEDULE 13G/A Freenome, Inc. Filed by: 683 Capital Management, LLC
August 12, 2026 11:13 AM - SEC Filing
FDA grants breakthrough device status to Freenome's lung cancer blood test
August 12, 2026 9:00 AM - StreetInsider
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
August 12, 2026 9:00 AM - StreetInsider
Form SCHEDULE 13G/A Freenome, Inc. Filed by: BIT Capital GmbH
August 5, 2026 6:27 AM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: Waksal Harlan
July 29, 2026 5:19 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Elliott Aaron Matthew
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Nuechterlein Carole
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Scott Randal W.
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Lin Cheng-Ho Jimmy
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Ennis Riley Charles
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: PAKIANATHAN DEEPIKA
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Costello Ann Catherine
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Le Linh H.
July 27, 2026 8:48 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: VAN OORT DOUGLAS M
July 27, 2026 8:48 PM - SEC Filing
FDA approves Freenome's blood-based colorectal cancer screening test
July 27, 2026 8:00 AM - StreetInsider
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
July 27, 2026 8:00 AM - StreetInsider
Form 4 Freenome, Inc. For: Jul 20 Filed by: SONG KENNETH
July 24, 2026 4:08 PM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: Perceptive Capital Solutions Holdings
July 23, 2026 4:49 PM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: EDELMAN JOSEPH
July 22, 2026 9:08 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: EDELMAN JOSEPH
July 22, 2026 8:51 PM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: McKenna Mark C.
July 22, 2026 7:21 PM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: Stone Adam Leo
July 22, 2026 7:20 PM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: ALTMAN MICHAEL SETH
July 22, 2026 7:18 PM - SEC Filing
Form 4 Freenome, Inc. For: Jul 20 Filed by: RA Capital Nexus Fund II, L.P.
July 22, 2026 5:31 PM - SEC Filing
Form 3 Freenome, Inc. For: Jul 20 Filed by: Kolchinsky Peter
July 22, 2026 5:27 PM - SEC Filing
Freenome begins trading on Nasdaq after $310M SPAC merger
July 20, 2026 4:01 PM - StreetInsider
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
July 20, 2026 4:01 PM - StreetInsider
Full Article List
